CDK4/6InhibitorsHormoneReplacementTherapyImmunotherapyPhyllodesTumorAdenocarcinomaCapecitabineCachexiaFibroadenomaIntraductalPapillomaDoxorubicinChemopreventionApoptosisAromataseInhibitorsMultimodalityTherapyBI-RADSTamoxifenCMFChemotherapyCyclophosphamideMorpheaEstrogen/EstradiolFlowCytometryChemotherapyFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.AbsoluteRiskAdvocacyBOCAAntibodyTherapy5-FluorouracilOvarianSuppressionSelf-examinationNeoadjuvantTherapyPARPInhibitorsBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55BreastCancerGuaranteedRenewableInsuranceEGFR1 in 8womenAnastrozoleDimplingCytostaticDoseDenseTherapyLCISBiopsyGailModelPrecisionMedicineAngiogenesisCAMRaloxifeneSERMAntiemeticsAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerACChemotherapyKi-67RateFamilyHistoryLumpWomen ages40+ shouldhave a clinicalbreast examat least yearlyGeneticCounselingPhysicalactivity mayreduce therisk of breastcancersProgestinGermlineMutationPathologicResponseLapatinibMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltStagingIn-situCarcinomaTyrosine-KinaseInhibitorCalcificationsPalpationRADEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearAdjuvantTherapyMetastasisAlopeciaRadiotherapyBrachytherapyLymphoscintigraphyPalbociclibECOGScoreMRIAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenGeneMutationPaclitaxelHER-2Triple +/-BreastCancerBevacizumabBRCAGeneKappaEpsilonMastodyniaAyurvedaMegestrolAcetatemTORInhibitorsDefinitiveSurgeryHerceptinTumorGradeMastectomyLumpectomyMethotrexateFISHRelapseWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.DocetaxelPagetDiseaseDown-StagingCystMultifocalTumorsOligometastasesCheckpointInhibitorLymphNodeStatusCo-survivorBreastTomosynthesisHormoneReceptorStatusGeneticPredispositionCytotoxicER+/-BilateralProphylacticMastectomyPI3KinaseInhibitorsCDK4/6InhibitorsHormoneReplacementTherapyImmunotherapyPhyllodesTumorAdenocarcinomaCapecitabineCachexiaFibroadenomaIntraductalPapillomaDoxorubicinChemopreventionApoptosisAromataseInhibitorsMultimodalityTherapyBI-RADSTamoxifenCMFChemotherapyCyclophosphamideMorpheaEstrogen/EstradiolFlowCytometryChemotherapyFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.AbsoluteRiskAdvocacyBOCAAntibodyTherapy5-FluorouracilOvarianSuppressionSelf-examinationNeoadjuvantTherapyPARPInhibitorsBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55BreastCancerGuaranteedRenewableInsuranceEGFR1 in 8womenAnastrozoleDimplingCytostaticDoseDenseTherapyLCISBiopsyGailModelPrecisionMedicineAngiogenesisCAMRaloxifeneSERMAntiemeticsAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerACChemotherapyKi-67RateFamilyHistoryLumpWomen ages40+ shouldhave a clinicalbreast examat least yearlyGeneticCounselingPhysicalactivity mayreduce therisk of breastcancersProgestinGermlineMutationPathologicResponseLapatinibMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltStagingIn-situCarcinomaTyrosine-KinaseInhibitorCalcificationsPalpationRADEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearAdjuvantTherapyMetastasisAlopeciaRadiotherapyBrachytherapyLymphoscintigraphyPalbociclibECOGScoreMRIAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenGeneMutationPaclitaxelHER-2Triple +/-BreastCancerBevacizumabBRCAGeneKappaEpsilonMastodyniaAyurvedaMegestrolAcetatemTORInhibitorsDefinitiveSurgeryHerceptinTumorGradeMastectomyLumpectomyMethotrexateFISHRelapseWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.DocetaxelPagetDiseaseDown-StagingCystMultifocalTumorsOligometastasesCheckpointInhibitorLymphNodeStatusCo-survivorBreastTomosynthesisHormoneReceptorStatusGeneticPredispositionCytotoxicER+/-BilateralProphylacticMastectomyPI3KinaseInhibitors

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
  1. CDK4/6 Inhibitors
  2. Hormone Replacement Therapy
  3. Immunotherapy
  4. Phyllodes Tumor
  5. Adenocarcinoma
  6. Capecitabine
  7. Cachexia
  8. Fibroadenoma
  9. Intraductal Papilloma
  10. Doxorubicin
  11. Chemoprevention
  12. Apoptosis
  13. Aromatase Inhibitors
  14. Multimodality Therapy
  15. BI-RADS
  16. Tamoxifen
  17. CMF Chemotherapy
  18. Cyclophosphamide
  19. Morphea
  20. Estrogen/Estradiol
  21. Flow Cytometry
  22. Chemotherapy
  23. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  24. Absolute Risk
  25. Advocacy
  26. BOCA
  27. Antibody Therapy
  28. 5-Fluorouracil
  29. Ovarian Suppression
  30. Self-examination
  31. Neoadjuvant Therapy
  32. PARP Inhibitors
  33. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  34. Breast Cancer
  35. Guaranteed Renewable Insurance
  36. EGFR
  37. 1 in 8 women
  38. Anastrozole
  39. Dimpling
  40. Cytostatic
  41. Dose Dense Therapy
  42. LCIS
  43. Biopsy
  44. Gail Model
  45. Precision Medicine
  46. Angiogenesis
  47. CAM
  48. Raloxifene
  49. SERM
  50. Antiemetics
  51. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  52. AC Chemotherapy
  53. Ki-67 Rate
  54. Family History
  55. Lump
  56. Women ages 40+ should have a clinical breast exam at least yearly
  57. Genetic Counseling
  58. Physical activity may reduce the risk of breast cancers
  59. Progestin
  60. Germline Mutation
  61. Pathologic Response
  62. Lapatinib
  63. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  64. Staging
  65. In-situ Carcinoma
  66. Tyrosine-Kinase Inhibitor
  67. Calcifications
  68. Palpation
  69. RAD
  70. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  71. Adjuvant Therapy
  72. Metastasis
  73. Alopecia
  74. Radiotherapy
  75. Brachytherapy
  76. Lymphoscintigraphy
  77. Palbociclib
  78. ECOG Score
  79. MRI
  80. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  81. Gene Mutation
  82. Paclitaxel
  83. HER-2
  84. Triple +/- Breast Cancer
  85. Bevacizumab
  86. BRCA Gene
  87. Kappa Epsilon
  88. Mastodynia
  89. Ayurveda
  90. Megestrol Acetate
  91. mTOR Inhibitors
  92. Definitive Surgery
  93. Herceptin
  94. Tumor Grade
  95. Mastectomy
  96. Lumpectomy
  97. Methotrexate
  98. FISH
  99. Relapse
  100. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  101. Docetaxel
  102. Paget Disease
  103. Down-Staging
  104. Cyst
  105. Multifocal Tumors
  106. Oligometastases
  107. Checkpoint Inhibitor
  108. Lymph Node Status
  109. Co-survivor
  110. Breast Tomosynthesis
  111. Hormone Receptor Status
  112. Genetic Predisposition
  113. Cytotoxic
  114. ER +/-
  115. Bilateral Prophylactic Mastectomy
  116. PI3 Kinase Inhibitors